Department of Oral and Maxillofacial Surgery and Diagnostic Science, Riyadh Elm University, Kingdom of Saudi Arabia, Phone: +00966506275782, e-mail:
King Saud University, Kingdom of Saudi Arabia.
J Contemp Dent Pract. 2022 Dec 1;23(12):1280-1288. doi: 10.5005/jp-journals-10024-3444.
This study aimed to systematically review the published studies on vertical alveolar bone augmentation (VABA) by guided bone regeneration (GBR) with titanium mesh (TM).
Guided bone regeneration is a procedure that can be used for VABA of the alveolar ridge. Titanium mesh is used as a barrier due to its ability to maintain a space that the newly formed bone will occupy.
A computerized literature search was conducted on the databases PubMed, SCOPUS, Science Direct, and Cochrane Library to review the published article on VABA by TM from 2011 to 2021.
Eight out of 574 retrieved articles were included in the qualitative analysis, three randomized clinical trials, two prospective clinical trials, and three retrospective trials. They were assessed for risk of bias using the critical appraisal skills program checklist. Titanium mesh was utilized as a barrier in three different ways, adapted directly on the alveolar bone, bent preoperatively on three-dimensional (3D) models, and 3D-printed. Two randomized clinical trials (RCTs) reported 20.8% bone gain, while the other studies reported the means ranging from 2.56 to 4.78 mm. All studies reported TM exposure that ranged from 7.69 to 66.66%. Exposure during the four postoperative weeks led to inadequate bone regeneration. However, late exposure had no effect or caused only slight bone resorption. Early TM removal was performed in two studies, one case per each, ranging from 2.4 to 11.1%. Infection was presented in three studies, one case per each, and the percentages were 5, 11.1, and 25%.
All types of TM had exposure, which was the most common complication, but early removal was indicated only in a few cases. Titanium mesh showed reliability and efficacy as a barrier for VABA by GBR.
By this procedure, bone height can be restored, however, meticulous follow-up is recommended for the detection and management of TM exposures.
本研究旨在系统回顾经引导骨再生(GBR)用钛网(TM)行垂直牙槽骨增量(VABA)的已发表研究。
GBR 是一种可用于牙槽嵴 VABA 的程序。TM 因其能维持新骨将要占据的空间而被用作屏障。
对 PubMed、SCOPUS、Science Direct 和 Cochrane Library 数据库进行计算机文献检索,以回顾 2011 年至 2021 年间发表的关于 TM 行 VABA 的文章。
在 574 篇检索文章中,有 8 篇被纳入定性分析,包括 3 项随机临床试验、2 项前瞻性临床试验和 3 项回顾性试验。采用批判性评估技巧计划清单评估偏倚风险。TM 以三种不同的方式用作屏障:直接适形于牙槽骨、术前在三维(3D)模型上弯曲和 3D 打印。两项随机临床试验(RCT)报道了 20.8%的骨增量,而其他研究报道的均值范围为 2.56 至 4.78mm。所有研究均报道了 TM 暴露率,范围为 7.69 至 66.66%。在术后的 4 周内,暴露会导致骨再生不足。然而,晚期暴露无影响或仅引起轻微的骨质吸收。两项研究中各有 1 例进行了早期 TM 去除,时间分别为 2.4 至 11.1 天。有 3 项研究各报道了 1 例感染,百分比分别为 5%、11.1%和 25%。
所有类型的 TM 都有暴露,这是最常见的并发症,但只有少数情况下需要早期去除。TM 作为 GBR 行 VABA 的屏障具有可靠性和有效性。
通过该程序,可以恢复骨高度,但建议进行细致的随访,以发现和处理 TM 暴露。